NXTSNasdaqPharmaceutical PreparationsFiscal year ends December 31
Nexentis Technologies Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026
$0.64−0.00 (-0.73%)
Close on Oct 19, 2026
- Market cap
- $522.65K
- P/E (TTM)
- –
- Dividend yield
- –
Share price
−$26.8690 (−97.67%)past year
Daily closes, adjusted for splits. Drag across the chart to measure a change.Split
Key statistics
Valuation at the latest close; fundamentals over fiscal , balances at Jun 30, 2026
Valuation
- Market cap
- $522.65K
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.27
- Dividend yield
- –
- Free cash flow yield
- -731.27%
Fundamentals
- Net income
- -$16.03M
- EPS, diluted
- -$8.61
- Free cash flow
- -$3.82M
- Book value per share
- $2.33
- Diluted shares
- 1M
Eight years at a glance
Fiscal years 2018 to 2025 and trailing twelve months, USD
Revenue
–
Gross profit
–
Operating income
-$10.88M
Net income
-$16.03M
EPS, diluted
–
Free cash flow
–
Reported periodTrailing twelve months